The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Overall survival in platinum-sensitive recurrent ovarian cancer: Findings from a multinational medical record review.
 
Jerzy Tyczynski
Employment - Astellas Pharma; AstraZeneca/MedImmune
Research Funding - Astellas Pharma; AstraZeneca/MedImmune
Travel, Accommodations, Expenses - Astellas Pharma; AstraZeneca
 
Sarah Williams
No Relationships to Disclose
 
Noolie Gregory
Employment - AstraZeneca
Stock and Other Ownership Interests - AstraZeneca
 
Mandy Garratt
Employment - AstraZeneca
Stock and Other Ownership Interests - AstraZeneca
 
Ilian Tchakov
Employment - AstraZeneca
Stock and Other Ownership Interests - AstraZeneca
 
Keith L. Davis
Research Funding - AstraZeneca; Bristol-Myers Squibb; GlaxoSmithKline; Lilly; Novartis; Otsuka; Pfizer; Shire; Takeda
 
James A. Kaye
Stock and Other Ownership Interests - Abbott Laboratories (I); Abbvie (I); Baxter (I); Johnson & Johnson (I); Novartis (I)
Research Funding - Abbvie (Inst); Acceleron Pharma (Inst); Alcon (Inst); Alexion Pharmaceuticals (Inst); Amgen (Inst); Astellas Pharma (Inst); AstraZeneca (Inst); Bayer (Inst); Biogen (Inst); Boehringer Ingelheim (Inst); Bristol-Myers Squibb (Inst); Eisai (Inst); Galena Biopharma (Inst); Genentech (Inst); GlaxoSmithKline (Inst); Grifols (Inst); Helsinn Therapeutics (Inst); Incyte (Inst); Lilly (Inst); Mannkind (Inst); MedImmune (Inst); Merck (Inst); Merck KGaA (Inst); Millennium (Inst); Mundipharma (Inst); Novartis (Inst); Novo Nordisk (Inst); Onyx (Inst); Otsuka (Inst); Pfizer (Inst); Proacta (Inst); Sanofi (Inst); Seagen (Inst); Shire (Inst); Takeda (Inst); Telormedix (Inst); Teva (Inst)
 
Jennifer Korsnes
Research Funding - AstraZeneca (Inst); Bristol-Myers Squibb (Inst); GlaxoSmithKline (Inst); Iroko Pharmaceuticals (Inst); Lilly (Inst); Sunovion (Inst); Teva (Inst)
 
Jan Lewis
Employment - AstraZeneca
Stock and Other Ownership Interests - AstraZeneca